ZA957281B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA957281B
ZA957281B ZA957281A ZA957281A ZA957281B ZA 957281 B ZA957281 B ZA 957281B ZA 957281 A ZA957281 A ZA 957281A ZA 957281 A ZA957281 A ZA 957281A ZA 957281 B ZA957281 B ZA 957281B
Authority
ZA
South Africa
Prior art keywords
nizatidine
nitro
iii
ethenediamine
contg
Prior art date
Application number
ZA957281A
Other languages
English (en)
Inventor
Mary Kay Mccauley
Kenneth Philip Moder
Jeffrey Lynn Speakman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA957281B publication Critical patent/ZA957281B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA957281A 1994-08-30 1995-08-30 Pharmaceutical composition ZA957281B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,486 US5470865A (en) 1994-08-30 1994-08-30 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA957281B true ZA957281B (en) 1997-02-28

Family

ID=23150736

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957281A ZA957281B (en) 1994-08-30 1995-08-30 Pharmaceutical composition

Country Status (24)

Country Link
US (1) US5470865A (xx)
EP (1) EP0704214B1 (xx)
JP (1) JPH0892087A (xx)
KR (1) KR960006921A (xx)
CN (1) CN1127635A (xx)
AT (1) ATE192039T1 (xx)
AU (1) AU700488B2 (xx)
BR (1) BR9503832A (xx)
CA (1) CA2157240A1 (xx)
CO (1) CO4410183A1 (xx)
CZ (1) CZ189395A3 (xx)
DE (1) DE69516475T2 (xx)
ES (1) ES2145221T3 (xx)
FI (1) FI954050A (xx)
HU (1) HUT72672A (xx)
IL (1) IL115012A0 (xx)
NO (1) NO952825L (xx)
NZ (1) NZ272833A (xx)
PE (1) PE33696A1 (xx)
PH (1) PH31452A (xx)
PL (1) PL310207A1 (xx)
TR (1) TR199500885A2 (xx)
YU (1) YU57495A (xx)
ZA (1) ZA957281B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010068707A (ko) * 2000-01-07 2001-07-23 최용준 시계줄
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
KR102178793B1 (ko) * 2019-04-17 2020-11-13 황용석 순금 장식연결구

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
DE3486032T2 (de) * 1983-02-07 1993-05-19 Lilly Co Eli Synthese von nizatidin.
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
US4857344A (en) 1986-12-31 1989-08-15 Del Monte Corporation Method for treating pineapple to inhibit browning
DE3784698D1 (de) * 1987-04-06 1993-04-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
DE68910308D1 (de) * 1989-05-10 1993-12-02 Council Scient Ind Res Verfahren zur Herstellung von 1-amino-substituierten 1-thio-substituierten 2-Nitro Alkenen.
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5334725A (en) * 1991-05-21 1994-08-02 Eli Lilly And Company 2-aminomethyl-4-exomethylenethiazoline epoxides
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same

Also Published As

Publication number Publication date
CO4410183A1 (es) 1997-01-09
CN1127635A (zh) 1996-07-31
FI954050A0 (fi) 1995-08-29
NO952825D0 (no) 1995-07-17
PE33696A1 (es) 1996-08-29
EP0704214A1 (en) 1996-04-03
KR960006921A (ko) 1996-03-22
AU700488B2 (en) 1999-01-07
DE69516475D1 (de) 2000-05-31
HUT72672A (en) 1996-05-28
YU57495A (sh) 1999-07-28
JPH0892087A (ja) 1996-04-09
CA2157240A1 (en) 1996-03-01
IL115012A0 (en) 1996-01-31
ES2145221T3 (es) 2000-07-01
AU3033495A (en) 1996-03-14
HU9502542D0 (en) 1995-10-30
FI954050A (fi) 1996-03-02
NO952825L (no) 1996-03-01
ATE192039T1 (de) 2000-05-15
DE69516475T2 (de) 2000-09-28
US5470865A (en) 1995-11-28
CZ189395A3 (en) 1996-03-13
BR9503832A (pt) 1996-09-10
PH31452A (en) 1998-11-03
EP0704214B1 (en) 2000-04-26
TR199500885A2 (tr) 1996-06-21
PL310207A1 (en) 1996-03-04
NZ272833A (en) 1997-04-24

Similar Documents

Publication Publication Date Title
ES8205789A1 (es) Un procedimiento para la preparacion de derivados del indol
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
PT75210B (en) A method of minimizing water loss from a water-containing topical preparation and a process for preparing said preparation
JPS53129262A (en) Method of surface treatment
PT72435A (en) Process for the preparation of 2-/2-(1,4-benzodioxanyl)/-2-imidazoline and salts there of having pharmaceutical effect
FR2722475B1 (fr) Installation pour le traitement a haute pression de denrees sous emballages souples
HU9502542D0 (en) Pharmaceutical composition
ATE201882T1 (de) Formulierung von energie
JPS5636419A (en) Medical treating agent for skin
RU96115481A (ru) Способ лечения деформирующего остеоартроза крупных суставов
ATE153330T1 (de) Neues verfahren zur herstellung von clonidin- derivaten
PH19228A (en) N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof
YU260882A (en) Process for preparing n-(2-(*(5-(dimethyl-amino)-methyl-2-furanyl)-methyl*-thio)-ethyl*-n'-methyl-2-nitro-1,1-ethene diamine
SU814997A1 (ru) Способ обработки бетонных изделий
ZA808014B (en) N-(3-(1'-3"-oxapentamethyleneamino-ethylideneamino)-2,4,6-triiodobenzoyl)- -amino -methylpropionitrile
FR2601386B1 (fr) Procede de bioconversion selective du dinitrate d'isosorbitol
JPS5526881A (en) Semisynthesis of insulin
FR2618335B1 (fr) Extrait de cochlospermum planchonii, procede de preparation et utilisation therapeutique
SE9000658D0 (sv) Mittel zur behandlung der schlaf-apnoe
AU3357793A (en) Process for cotton treatment by hot steam injection and plant for carrying out said process
FI972528A (fi) Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi
IT1169237B (it) Metodo per l'isolamento e la purificazione della n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etendiamina
JPS525951A (en) Heat recovering method in heat treatment of mud
YU309780A (en) Process for preparing n-(3-(1,3"-oxapantamethyleneaminoethyl-indine amino)-2,4,6-triiodobenzoyl)-gamma-amino-alpha-methyl-propionic acid